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Abstract
Background: In the early stages of development of the cellular slime mold Dictyostelium discoideum, chemotaxis toward
cAMP plays a pivotal role in organizing discrete cells into a multicellular structure. In this process, a series of signaling
molecules, such as G-protein-coupled cell surface receptors for cAMP, phosphatidylinositol metabolites, and cyclic
nucleotides, function as the signal transducers for controlling dynamics of cytoskeleton. Differentiation-inducing factor-1
and -2 (DIF-1 and DIF-2) were originally identified as the factors (chlorinated alkylphenones) that induce Dictyostelium stalk
cell differentiation, but it remained unknown whether the DIFs had any other physiologic functions.
Methodology/Principal Findings: To further elucidate the functions of DIFs, in the present study we investigated their
effects on chemotaxis under various conditions. Quite interestingly, in shallow cAMP gradients, DIF-1 suppressed
chemotaxis whereas DIF-2 promoted it greatly. Analyses with various mutants revealed that DIF-1 may inhibit chemotaxis,
at least in part, via GbpB (a phosphodiesterase) and a decrease in the intracellular cGMP concentration ([cGMP]i). DIF-2, by
contrast, may enhance chemotaxis, at least in part, via RegA (another phosphodiesterase) and an increase in [cGMP]i. Using
null mutants for DimA and DimB, the transcription factors that are required for DIF-dependent prestalk differentiation, we
also showed that the mechanisms for the modulation of chemotaxis by DIFs differ from those for the induction of cell
differentiation by DIFs, at least in part.
Conclusions/Significance: Our findings indicate that DIF-1 and DIF-2 function as negative and positive modulators for
Dictyostelium chemotaxis, respectively. To our knowledge, this is the first report in any organism of physiologic modulators
(small molecules) for chemotaxis having differentiation-inducing activity.
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Introduction
Chemotaxis—a fundamental cellular function for sensing the
direction of extracellular stimuli and migrating toward or away
from the source—is involved in various biological and physiologic
events, such as lymphocyte homing, angiogenesis, embryogenesis,
wound healing, and some inflammatory disorders [1–3]. Dictyos-
telium discoideum is an excellent model organism for the analysis of
both chemotaxis and cell differentiation. These vegetative
amoebae grow by eating bacteria, and upon starvation, start
morphogenesis. During morphogenesis, the cells gather to form a
slug-shaped multicellular aggregate that differentiates into two
distinct cell types (prespore and prestalk cells). Eventually, the cells
form a fruiting body consisting of spores and a multicellular stalk.
Extracellular cAMP is not only an essential substance for cell
differentiation but also a chemoattractant when the cells gather to
form a multicellular aggregate [4,5]. Recently, Dictyostelium
chemotaxis toward cAMP was shown to be regulated by several
key signaling pathways involving phosphoinositide-3-kinase
(PI3K), phospholipase A2 (PLA2), phospholipase C (PLC), and
cGMP [6–14], but the precise mechanisms controlling chemotaxis
are unclear.
Differentiation-inducing factor-1, -2, and -3 (DIFs 1–3) were
originally identified as the differentiation-inducing factors of stalk
cells in D. discoideum [15,16]. DIF-1 is the most active species in
inducing stalk cell differentiation, whereas DIF-3, the initial
product in DIF-1 breakdown, has only 3.5% of the activity of DIF-
1 [17,18]. In contrast, DIF-2 is neither a precursor nor a
metabolite of DIF-1 in vivo and possesses as much as 40% of the
specific activity of DIF-1 [17,19,20]. Thus, DIF-2 is a curious
compound, whose physiologic and specific roles, if any, are
unknown.
It has been suggested that DIF-1 and DIF-2 may have roles
other than inducing stalk cell differentiation during the early stage
of development [18]. To further elucidate the physiologic
functions of DIFs in early development, in the present study we
investigated the effects of DIF-1 and DIF-2 on chemotactic cell
movement toward various concentrations of cAMP. We show here
that in shallow cAMP gradients, DIF-1 and DIF-2 function as
negative and positive modulators for chemotaxis, respectively.
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Results and Discussion
Effects of DIFs on chemotaxis in Ax2 and HM1030 cells
We first studied Ax2 (wild type) cells starved for 4–8 h (Fig. 1B).
When 10–100 nM droplets of cAMP were put on agar, 100 nM of
DIFs did not significantly affect chemotactic movement. To our
surprise, however, in Ax2 cells starved for 6–8 h, DIF-1 inhibited
chemotaxis toward 0.1–1 nM cAMP, and DIF-2 promoted it
greatly; thus, despite their structural similarity (Fig. 1A), the DIFs
showed opposite effects on chemotaxis. These results suggest that
DIF-1 and DIF-2 function as modulators of chemotactic cell
movement toward cAMP in Ax2 cells that have been starved for
more than 6 h.
We next examined the net effects of exogenous DIF-1 and DIF-
2 on chemotaxis in dmtA- cells starved for 6 h; HM1030 (dmtA-) is a
mutant strain that lacks the des-methyl-DIF-1 methyltransferase
and thus cannot produce appreciable amounts of DIF-1 and DIF-
2 [21,22], although the mutant cells can gather to form
multicellular aggregates and eventually fruiting bodies [21]. In
the presence or absence of exogenous DIFs (100 nM each), dmtA-
and Ax2 cells showed similar chemotactic cell movement toward
low concentrations of cAMP (Fig. 1B). Note, however, that 10–
100 nM DIF-3, DMPH, and 2-MIDIF-1 did not affect chemotaxis
toward 0.1–100 nM cAMP in either Ax2 or dmtA- cells (Fig. 2),
indicating that the chemotaxis-modulating effects of DIF-1 and
DIF-2 are highly specific to their chemical structures.
We next examined the effects of physiologic concentrations
of DIFs (0.1–100 nM) on chemotaxis in dmtA- cells (Fig. 3A).
DIF-1 at 3–100 nM inhibited chemotaxis toward 10 nM
cAMP in a dose-dependent manner, whereas DIF-2 at 3–
100 nM promoted chemotaxis toward 0.1 and 1 nM cAMP in
a dose-dependent manner. We next assessed whether DIF-1
and DIF-2 competed with each other (Fig. 3B). As expected,
DIF-1 at 10 nM inhibited chemotaxis toward 10 nM cAMP,
and DIF-2 at 3–100 nM restored the DIF-1-inhibited chemo-
taxis in a dose-dependent manner. In clear contrast, DIF-2 at
10 nM promoted chemotaxis toward 0.1 and 1 nM cAMP, and
DIF-1 at 3–100 nM dose-dependently suppressed the DIF-2-
promoted chemotaxis.
Effects of DIFs on chemotaxis in dimA- and dimB-null cells
To investigate whether the DIFs modulate chemotaxis via cell
differentiation, we examined the effects on chemotaxis in the null
mutants for DimA and DimB, the transcription factors that are
required for DIF-dependent prestalk differentiation [23–25].
Quite interestingly, chemotactic cell movement was significantly
suppressed by DIF-1 and was well enhanced by DIF-2 in a dose-
dependent manner in the dimA- mutant (Fig. 4). By contrast, DIF-1
did not affect chemotaxis in either the dimB- or dimA-/B- mutants,
whereas DIF-2 promoted chemotaxis in all the mutants (Fig. 4).
These results suggest that DimA is not essential for the actions of
DIF-1 and DIF-2, whereas DimB is required for the action of DIF-
1 but not of DIF-2. In other words, DIF-1 should suppress
chemotaxis via DimB or DimB-inducible gene products, whereas
DIF-2 promotes chemotaxis via a DimA/DimB-independent
pathway. Thus, the mechanisms for the modulation of chemotaxis
by DIFs differ from those for the induction of cell differentiation by
DIFs, at least in part.
Effects of DIFs on chemotaxis in regA- and gbpB-null cells
We then examined the effects of the DIFs on chemotaxis in a
variety of mutants lacking the genes required for normal
chemotaxis (Fig. 5). Note that chemotaxis in shallow cAMP
gradients was greatly impaired in pi3k1-/2-, pten-, plaA-, and gca-/
sgc- cells, in which the chemotaxis-modulating effects of DIFs were
not observed (Fig. 5). This finding suggests that the activities of the
PI3-kinases, PTEN, PLA2, and the guanylylcyclases should be
required for normal chemotaxis in shallow gradients. However,
because pi-kinases/pten sextuple null (pi3ks-/pten-) cells exhibited a
normal chemotactic response to cAMP in the presence or absence
of DIFs (Fig. 5), the PI3-kinases and PTEN are likely not essential
for the modulation of chemotaxis by DIFs.
Our results in mutants lacking the cyclic nucleotide phopho-
diesterase (PDE) genes regA and gbpB [26,27] were particularly
striking. To our surprise, DIFs at 100 nM showed the same effects
of inhibiting chemotaxis in regA- cells and of enhancing chemotaxis
in gbpB- cells (Fig. 6A). In clear contrast, however, in regA- cells,
DIF-1 at 10 nM inhibited chemotaxis but DIF-2 at 10 nM did not
affect chemotaxis (Fig. 6B), whereas in gbpB- cells, DIF-2 at 10 nM
enhanced chemotaxis but DIF-1 at 10 nM did not affect
chemotaxis (Fig. 6B). These results strongly suggest that the
pathways by which DIF-1 and DIF-2 modulate chemotaxis involve
GbpB (PDE for cGMP) [27] and RegA (PDE for cAMP?) [28],
respectively, and that DIF-1 and DIF-2 at high concentrations (e.g.,
100 nM) may have the potential to cross-affect the other pathway
(Fig. 7B). More precisely, DIF-1 may inhibit chemotaxis, at least in
part, via GbpB activation and a subsequent decrease in the
intracellular cGMP concentration ([cGMP]i), whereas DIF-2 may
Figure 1. Effects of DIF-1 and DIF-2 on chemotaxis in Ax2 and
HM1030 (dmtA-) cells. (A) Chemical structure of DIF-1: 1-(3,5-dichloro-
2,6-dihydroxy-4-methoxyphenyl)hexan-1-one and DIF-2: 1-(3,5-dichloro-
2,6-dihydroxy-4-methoxyphenyl)pentan-1-one. (B) Ax2 and HM1030
cells were starved for 4–8 h (as indicated in parentheses) in shake-
culture, and cell droplets were spotted on PB agar containing 3 mM
caffeine (Control) plus 100 nM DIF-1 or DIF-2. Cells were assayed for
chemotaxis toward the indicated doses of cAMP (10 cell droplets were
examined for each cAMP concentration). Data are the mean and s.d.
(bars) of three independent experiments (n = 3). *P,0.05, as compared
with Control.
doi:10.1371/journal.pone.0006658.g001
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enhance chemotaxis, at least in part, via a RegA-dependent
pathway.
Effects of DIFs on [cGMP]i
To illustrate our hypothesis for the actions of DIFs (Fig. 7), we
further examined the effects of DIFs on [cGMP]i in Ax2, regA
-, and
gbpB- cells (Fig. 6A, B). Stimulation with cAMP induced a transient
increase in [cGMP]i within 20 s that was significantly inhibited by
10–100 nM DIF-1 and was enhanced by 10–100 nM DIF-2 in
Ax2 cells. In regA- cells, as expected, the cAMP-
induced increase in [cGMP]i was inhibited by 10–100 nM DIF-
1 or 100 nM DIF-2 and was not affected by 10 nM DIF-2. In
gbpB- cells, in contrast, the cAMP-induced increase in [cGMP]i
was enhanced by 10–100 nM DIF-2 or 100 nM DIF-1 but
was not affected by 10 nM DIF-1. These results strongly
support our hypothesis for the actions of DIFs in chemotaxis
(Fig. 7).
Expression of regA and gbpB in dimA- and dimB-null cells
To confirm that RegA and GbpB are involved in DIF-
modulated chemotaxis, we investigated the relation between
responsiveness to DIFs and expression of the PDEs in dimA- and
dimB- cells (Fig. 4C). Indeed, regA was expressed in all mutants
in which chemotaxis was enhanced by DIF-2. Furthermore,
gbpB mRNA was expressed in dimA- cells in which chemotaxis
was inhibited by DIF-1, whereas gbpB mRNA was not ex-
pressed in dimB- cells in which chemotaxis was not affected
by DIF-1. These results support our model in which the effects
of DIF-1 and DIF-2 are GbpB- and RegA-dependent,
respectively.
Conclusions
Various indirect evidence suggests that DIFs may have novel
functions in controlling cellular movement (e.g., chemotaxis) during
Figure 2. Effects of DIF analogs on chemotaxis in Ax2 and HM1030 cells. (A) DIF-3: 1-(3-chloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-
one. 2-MIDIF-1: 2-methoxy isomer of DIF-1. DMPH: 1-(2,6-dihydroxy-4-methoxyphenyl)hexan-1-one. (B) Ax2 and HM1030 cells starved for 6 h were
spotted on PB agar containing 3 mM caffeine (Control) plus the indicated concentrations of DIF-3, DMPH, or 2-MIDIF-1 (2-MID) and assayed for
chemotaxis toward the indicated doses of cAMP. Data are the mean and s.d. (bars) of three independent experiments (n = 3).
doi:10.1371/journal.pone.0006658.g002
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early development. First, as measured by a bioassay based on stalk
cell induction, a major rise in DIF levels occurs at the end of
aggregation, and low levels of DIF activity are detected during the
early aggregation stage [29,30]. In addition, DmtA is detectable at
3–6 h of development [21]. Second, cAMP relay is inhibited by
DIF-1 in aggregation-competent cells [31]. Third, as measured by
monitoring light-scattering cellular responses and cyclic nucleotide
production in in vitro cell suspensions, DIFs may affect cell shape
(or cohesion) and the levels of cAMP and cGMP in early stages of
development [18].
Here, we have elucidated the novel functions of DIFs. We
found that DIF-1 and DIF-2 function as negative and positive
modulators of D. discoideum chemotaxis, respectively, in shallow
cAMP gradients. Because we performed our experiments in the
presence of caffeine, an inhibitor of endogenous cAMP
production (cAMP relay), we were able to elucidate the net
and intrinsic effects of DIFs on cellular cGMP levels and
chemotaxis toward very low levels of exogenous cAMP; thus,
the mechanisms underlying the actions of DIFs in chemotaxis
in vivo would be more complicated than described in
Fig. 7B.
In our model, we assume that GbpB activation by DIF-1
suppresses cAMP-stimulated cGMP production and that DIF-2
somehow promotes cAMP-stimulated cGMP production via a
RegA-dependent pathway. Bosgraaf et al. [27] showed that
GbpB is a PDE for cGMP, which supports our model with
respect to the GbpB-dependent action of DIF-1. However,
because Shaulsky et al. [28] have shown with recombinant RegA
that RegA is a PDE that is specific to cAMP but not to cGMP,
RegA might affect cellular cGMP levels indirectly. Still, it is
possible that RegA directly degrades cGMP in vivo in the presence
of some co-factor or co-factors; if so, DIF-2 would promote
chemotaxis via RegA inhibition and a subsequent increase in
[cGMP]i. At any rate, DIF-2 promotes cAMP-stimulated cGMP
production and chemotaxis when RegA is present (Fig. 4C, 6),
and our model agrees well with a general notion that intracellular
cGMP regulates myosin filament formation and thus chemotaxis
[32–36]. To our knowledge, this is the first report in any
Figure 3. Dose and combined effects of DIF-1 and DIF-2 on chemotaxis in HM1030 (dmtA-). (A) Effects of DIF concentrations on
chemotaxis. HM1030 cells starved for 6 h were spotted on PB agar containing 3 mM caffeine plus various concentrations of DIF-1 (top) or DIF-2
(middle and bottom) and assayed for chemotaxis toward the doses of cAMP indicated in square brackets. Data are the mean and s.d. (bars) of three
independent experiments (n = 3). (B) Combined effects of DIF-1 and DIF-2 on chemotaxis. HM1030 cells starved for 6 h were spotted on PB agar
containing 3 mM caffeine plus 10 nM DIF-1 in combination with the various concentrations of DIF-2 (top) or plus 10 nM DIF-2 in combination with
the various concentrations of DIF-1 (middle and bottom) and assayed for chemotaxis toward the doses of cAMP indicated in square brackets. Data
are the mean and s.d. (bars) of three independent experiments (n = 3). *P,0.05, as compared with **Control.
doi:10.1371/journal.pone.0006658.g003
Modulators for Chemotaxis
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organism of physiologic modulators for chemotaxis having
differentiation-inducing activity. Furthermore, our findings
suggest that cell differentiation inducers (small molecules) may
function as key modulators for chemotaxis and thus for
morphogenesis in other organisms as well.
Although it is not known how DIFs control RegA and GbpB
activity, because DIFs have been shown to directly inhibit
calmodulin-dependent PDE1 (specific to cAMP and cGMP) and
suppress cell growth in mammalian cells [37,38], RegA or GbpB
may be direct targets of DIFs in D. discoideum. Furthermore, DIFs
may modulate mammalian chemotaxis via PDE1 or other PDEs; if
so, some DIF derivatives might be utilized as drugs to control
mammalian chemotaxis for basic research and therapeutic
purposes.
Because joining a multicelluar aggregate and differentiating
into spores may be essential to survival and reproduction in the
social amoeba D. discoideum, rapid and slow movement toward
aggregates modulated by DIFs may affect fitness. In nature, D.
discoideum cells would hardly synchronize the start of development
(starvation); thus, DIFs produced by senior cells would consid-
erably affect junior cells during development. The physiologic
and evolutionary significance of the modulators of chemotaxis
and the detailed mechanisms of their actions should be elucidated
further.g
Materials and Methods
Dictyostelium discoideum strains and DIF
The dmtA- [21], regA- [26], gbpA-, gbpB-, gbpA-/gbpB-, gbpD-
[27,33,34], gcA-/sgc- [39], pi3k1-/pi3k2- [6], pten- [7], dimA-,
dimB-, and dimA-/B- [23–25] strains have been described
previously. The plaA- strain was generated by transforming
Figure 4. Effects of DIF-1 and DIF-2 on chemotaxis in Dim mutants. (A) Starved (for 6 h) dimA-, dimB-, and dimA-/B- cells were spotted on PB
agar containing 3 mM caffeine (Control) plus 100 nM DIF-1 or DIF-2 and assayed for chemotaxis toward the indicated doses of cAMP. Data are the
mean and s.d. (bars) of three independent experiments (n = 3). (B) Starved dimA-, dimB-, and dimA-/B- cells were spotted on PB agar containing 3 mM
caffeine plus the indicated concentrations of DIF-1 or DIF-2 and assayed for chemotaxis toward the doses of cAMP indicated above in square
brackets. Data are the mean and s.d. (bars) of three independent experiments (n = 3). *P,0.05, as compared with Control. (C) Expression levels of regA
and gbpB. Cells were starved for 6 h, and RNAs collected from the cells were used for semi-quantitative RT-PCR to detect regA, gbpB, and rnlA (internal
control).
doi:10.1371/journal.pone.0006658.g004
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Ax2 cells with a gene disruption construct made by inserting
the bsr cassette into the EcoRV site of the genomic region of
the plaA ORF. DIFs were obtained as previously described
[38,40].
Cell culture
Cells were cultured at 21uC in HL5 medium with 100 mg/mL
streptomycin sulfate and 100 units/mL benzylpenicillin potassi-
um, as previously described [41]. For culturing the gene null
transformants, the HL5 medium was supplemented with 10 mg/
mL blasticidin S.
Chemotaxis assay
The chemotaxis assay was performed by the small population
assay as previously described with a few modifications [13]. Cells
were harvested by centrifugation (3506g) for 2 min, washed in
phosphate buffer (PB) (10 mM KH2PO4/Na2HPO4, pH 6.5),
and starved at a density of 16107 cells/mL in PB buffer for 1 h.
Then cAMP was added for 5 h in a pulsatile fashion every 6 min
to a final concentration of 30 nM. Starved cells were resus-
pended in PB, washed twice in PB, and resuspended in PB to a
final concentration of 56106 cells/mL. Ten,0.2-mL droplets of
starved cells were placed on a plate containing 10 mL of non-
nutrient hydrophobic agar (10 mM KH2PO4/Na2HPO4,
pH 6.5, 0.7% hydrophobic agar containing 3 mM caffeine).
Chemotaxis toward cAMP was tested after 30 min by placing a
second 0.1-mL droplet, with the indicated amount of cAMP, next
to the droplet of cells. The distribution of the cells in the droplet
was observed after 30 and 60 min, and they were scored
‘positive’ when at least twice as many cells were pressed against
the side of the population closer to the higher cAMP
concentration as against the other side of the droplet. The
percentage of ‘positive’ droplets was assessed, and the mean
values of three independent experiments are presented with
standard deviations (s.d.).
cGMP assay
cGMP was assayed as described previously by using the starved
cells resuspended in PB containing 3 mM caffeine [42].
Semi-quantitative RT–PCR gene expression analysis
Total RNA was prepared by use of RNeasy mini kits (Qiagen,
Hilden, Germany). cDNA was synthesized by Superscript II
(Invitrogen, Carlsbad, CA) with a random DNA hexamer. Semi-
quantitative RT–PCR was performed by using a KOD plus
(TOYOBO, Osaka, Japan). PCRs were carried out with the
following program: one cycle of 120 s at 94uC followed by 28
cycles (for rnlA and regA) and 35 cycles (for gbpB) consisting of 20 s
at 94uC, 30 s at 55uC, 60 s at 65uC, and by one cycle of 60 s at
65uC. The following primer sets were used: regA, GCAA-
Figure 5. Effects of DIF-1 and DIF-2 on chemotaxis of various mutants. Various mutants starved for 6 h were spotted on PB agar containing
3 mM caffeine (Control) plus 100 nM DIF-1 or DIF-2 and assayed for chemotaxis toward the indicated doses of cAMP. Data are the mean and s.d.
(bars) of three independent experiments (n = 3). *P,0.05, as compared with Control. pi3k1 and pi3k2: genes of phosphoinositide-3 kinase. pten:
phasphotase and tensin homolog gene. plaA: phospholipase A2 gene. gca and sgc: genes of guanylyl cyclase A and soluble guanylyl cyclase. gbpA,
gbpB, and gbpD: genes of cGMP-binding protein A, B, and D, respectively. Note that chemotaxis toward low concentrations of cAMP was impaired in
pi3k1-/2-, pten-, plaA-, and gca-/sgc-, in which the chemotaxis-modulating effects of DIFs were not observed, and that DIFs showed essentially the
same effects in gbpA-/B- as seen in gbpB- cells (Fig. 6A).
doi:10.1371/journal.pone.0006658.g005
Modulators for Chemotaxis
PLoS ONE | www.plosone.org 6 August 2009 | Volume 4 | Issue 8 | e6658
GAATCGCAGCGGATTTC and TGTATGCTTGCCAAT-
TTTCACG; gbpB, CTTCGGTGGGTACAGTTGTG and
AAGCAAACGTCAGTCTCTGC; rnlA, GAGGCGCTGGT-
GAAATAGTAAG and ACTCTTTAGAAGGTTACCGCCC
(mitochondrial large subunit rRNA; internal control).
Statistical analysis
Statistical analysis was performed by using unpaired Student’s
t-test (two-tailed). Values of P,0.05 were considered signi-
ficant.
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Figure 6. Effects of DIF-1 and DIF-2 on chemotaxis and intracellular cGMP in Ax2, regA-, and gbpB- cells. (A, B) Cells starved for 6 h
were spotted on PB agar containing 3 mM caffeine (Control) plus 100 nM (A) or 10 nM (B) of DIF-1 or DIF-2 and assayed for chemotaxis toward
the indicated doses of cAMP (top). Starved cells in shake-culture were stimulated with 0.3 nM cAMP (final concentration) in the presence of
3 mM caffeine (Control) plus 100 nM (A) or 10 nM (B) of DIF-1 or DIF-2, and aliquots of the cells were collected for assay of cGMP contents
(bottom). Data are the mean and s.d. (bars) of three independent experiments (n = 3). *P,0.05, as compared with Control.
doi:10.1371/journal.pone.0006658.g006
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